CVS
CVS Health Corporation
Healthcare · in the S&P 500
📍 Rhode Island, United States · See it on the company map
The shape of the figures
Each spoke is one ratio. Further out means a higher figure than more of the index — not a better one. A high P/E or high debt sits far out too, so the size of the shape is not a score.
Drag to turn the shape. Tap or point at a dot to read the figure behind it.
The figures and what each one means are below. A hollow dot means the company doesn't report that figure.
Figures from the annual reports are unavailable right now — please try again in a minute.
Key figures, against the S&P 500
Figures as of 9 Nov 2026, refreshed weekly
Each bar places this company among the S&P 500 companies that report that figure. Further right means a higher figure — not a better one. Whether higher or lower suits you depends on what you are looking for, so the bars don't add up to a score.
Valuation
P/E ratio?
9.9x
The share price is 9.9 times the last twelve months' earnings per share.
P/E on average earnings?
22.8x
The share price is 22.8 times earnings per share averaged over recent years.
Price / book
1.4x
The market values the company at 1.4 times the accounting value of its equity.
EV / EBIT?
32.0x
The company's value including its debt is 32 times its operating profit.
Free cash flow yield?
10.9%
Free cash flow equals 10.9% of the company's market value.
Profitability
Return on equity?
14.4%
Each 100 of shareholders' money produced 14.4 of net profit.
Return on assets?
3.1%
Each 100 of assets produced 3.1 of net profit.
Return on invested capital
3.0%
Each 100 invested by lenders and owners produced 3 of profit.
Operating margin?
1.3%
Of every 100 in sales, 1.3 was left as operating profit.
Debt
Debt / equity?
93.3%
Total debt equals 93% of shareholders' equity.
Net debt / EBITDA?
3.5x
Net debt equals 3.5 years of operating earnings (EBITDA).
Interest cover
1.7x
Operating profit was 1.7 times the interest bill.
Growth
Revenue growth
14.5%
Latest revenue is 14.5% above the average of earlier reported years.
Earnings growth
-69.3%
Latest net profit is 69.3% below the average of earlier reported years.
⚠️ Not financial advice
This is a personal project, not professional investment research. The underlying market data may be delayed or incorrect. Nothing here is a recommendation to buy or sell any security. Always do your own research and consult a qualified professional before investing.
This tool is for informational and planning purposes only. It does not constitute financial, investment, tax or legal advice. Always consult a qualified professional before making financial decisions.